How to best plan the key study endpoints?

How to best plan the key study endpoints?

Properly defining study endpoints is one of the most critical steps in designing a clinical trial, medical experiment, or non-interventional study. Endpoints determine what we aim to demonstrate and how we will assess the efficacy and safety of the investigational medicinal product or medical device. To be meaningful, endpoints must derive directly from the study objective, have a clear and unambiguous definition, and rely on measurable and validated parameters. Maintaining a structured hierarchy is essential—starting with the primary endpoint, followed by secondary and exploratory endpoints, which support hypothesis generation. A well-defined structure improves interpretability of results and reduces the risk of statistical errors.

It is equally important to align with current regulatory standards such as ICH E6(R3), ICH E9, and EMA or FDA guidelines. This ensures that the endpoint is not only methodologically sound but also acceptable during regulatory assessment. When planning endpoints, practical site capabilities should also be considered—equipment availability, medical staff workload, and measurement frequency. Overly complex or burdensome endpoints may reduce data quality or complicate participant recruitment.

Collaboration with a statistician is a crucial step. A biostatistician verifies whether the proposed endpoint, given the planned sample size, provides sufficient statistical power, assesses its robustness to missing data, and determines the most appropriate analytical models. It is also advisable to review previous studies or pilot data to confirm that the endpoint is realistic, reproducible, and sensitive to treatment effects.

Well-designed endpoints increase study reliability, facilitate regulatory submissions, and improve the likelihood of obtaining clear, clinically meaningful results. They represent a strategic component that can determine the overall success of a clinical project.

If you want to ensure that the endpoints planned for your study fully support its objectives, schedule a free consultation with our experts — we will help you refine the initial study concept.

Other questions: Research planning and concept

See also

How to identify key study risks at an early stage and plan actions to minimize their impact? How to identify key study risks at an early stage and plan actions to minimize their impact?
Modern clinical trials increasingly rely on the Quality by Design (QbD) approach, which assumes that quality should not be “controlled” at the end of the pro...
How do inclusion and exclusion criteria affect recruitment speed and study duration? How do inclusion and exclusion criteria affect recruitment speed and study duration?
Inclusion and exclusion criteria are one of the key elements of clinical trial design. Although they are often viewed primarily as a tool to ensure populatio...
How to properly plan inclusion and exclusion criteria in a study? How to identify which of them may pose the greatest challenges and how to address them? How to properly plan inclusion and exclusion criteria in a study? How to identify which of them may pose the greatest challenges and how to address them?
Proper planning of inclusion and exclusion criteria is one of the key elements of a study protocol—it directly affects participant safety, data quality, and ...
Copyright© 2023 Biostat